PK Modulator Shows Promise in Thalassemia

(MedPage Today) -- In a small study, the allosteric pyruvate kinase (PK) modulator mitapivat (Pyrukynd) was effective in treating hemolytic anemia in patients with α-thalassemia and β-thalassemia who are not dependent on transfusions...
Source: MedPage Today Hematology/Oncology - Category: Hematology Source Type: news